SOLARA ACTIVE PHARMA SCIENCESSOLARA ACTIVE PHARMA SCIENCESSOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES

No trades
See on Supercharts
Market capitalization
‪15.22 B‬INR
−85.65INR
‪−221.80 M‬INR
‪14.27 B‬INR
‪14.74 M‬
Beta (1Y)
1.67

About SOLARA ACTIVE PHARMA SCIENCES

CEO
Poorvank Purohit
Headquarters
Chennai
Employees (FY)
‪3.46 K‬
Founded
2017
ISIN
INE624Z01016
FIGI
BBG00G9GRN81
Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. Its products include NSAID, anaesthetic, analgesics, antiviral, retinod, anti-emetic, antimalrial, diuretic, muscle relaxant, antiallergics, antihypertensive, calcimimetic agent, anti sezure, antigout, cardiovascular, anti-infective, cough suppressant, anti-ulcerative, anesthetic, antiepileptic, antirheumatic, skin disorder, cardiovascular agent, aplha or beta antagonist, hyperphosphatamia, atypical antipsychotic, antineoplastic adjunct, anti psoriasis, barbiturate dervicative, treatment of overactive bladder, gastro-intestinal, atypical antipsychotic, antihyperlipidemic, antihelmintic, gastrointestinal, antibiotic, phenylalanine reducer, anticholetithic, and anti depressant. The company was founded on February 23, 2017 and is headquartered in Chennai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SOLARA is 477.00 INR — it has increased by 12.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SOLARA ACTIVE PHARMA SCIENCES stocks are traded under the ticker SOLARA.
SOLARA ACTIVE PHARMA SCIENCES is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
SOLARA stock is 16.77% volatile and has beta coefficient of 1.67. Check out the list of the most volatile stocks — is SOLARA ACTIVE PHARMA SCIENCES there?
One year price forecast for SOLARA ACTIVE PHARMA SCIENCES has a max estimate of 300.00 INR and a min estimate of 300.00 INR.
SOLARA earnings for the last quarter are 1.00 INR whereas the estimation was 1.00 INR which accounts for 0% surprise. Estimated earnings for the next quarter are −5.30 INR. See more details about SOLARA ACTIVE PHARMA SCIENCES earnings.
SOLARA ACTIVE PHARMA SCIENCES revenue for the last quarter amounts to ‪4.25 B‬ INR despite the estimated figure of ‪3.81 B‬ INR. In the next quarter revenue is expected to reach ‪4.38 B‬ INR.
Yes, you can track SOLARA ACTIVE PHARMA SCIENCES financials in yearly and quarterly reports right on TradingView.
SOLARA stock has risen by 11.66% compared to the previous week, the month change is a 26.98% rise, over the last year SOLARA ACTIVE PHARMA SCIENCES has showed a 27.08% increase.
Like other stocks, SOLARA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOLARA ACTIVE PHARMA SCIENCES stock right from TradingView charts — choose your broker and connect to your account.
SOLARA reached its all-time high on May 19, 2021 with the price of 1859.30 INR, and its all-time low was 133.50 INR and was reached on Jul 13, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪3.46 K‬ employees. See our rating of the largest employees — is SOLARA ACTIVE PHARMA SCIENCES on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SOLARA ACTIVE PHARMA SCIENCES technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SOLARA ACTIVE PHARMA SCIENCES stock shows the buy signal. See more of SOLARA ACTIVE PHARMA SCIENCES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SOLARA ACTIVE PHARMA SCIENCES future price: according to them, SOLARA price has a max estimate of 300.00 INR and a min estimate of 300.00 INR. Read a more detailed SOLARA ACTIVE PHARMA SCIENCES forecast: see what analysts think of SOLARA ACTIVE PHARMA SCIENCES and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOLARA ACTIVE PHARMA SCIENCES EBITDA is ‪−561.70 M‬ INR, and current EBITDA margin is 8.35%. See more stats in SOLARA ACTIVE PHARMA SCIENCES financial statements.